Major Oral Remedies for Erectile Dysfunction
Erectile dysfunction (ED), as according to medical research and surveys became a common problem by many males since the 1990s.
The causes of erectile dysfunction may vary because it involves the integration of psychological, neurological, endocrinal, vascular and anatomical systems of males.
Once there are abnormalities in one or two or any of these systems, erectile dysfunction may take place.
The prevalence of the erectile dysfunction has been noted that through the number of years and years of researches and studies, it was found out that the prevalence of erectile dysfunction increases with age.
With the prevalent problems, remedies and medical treatments were developed, both surgical and nonsurgical.
Today, most patients prefer the non-surgical treatment though there are a lot of treatment approaches to choose from.
It is clear that oral therapy has revolutionized through scientific discoveries of drugs which inhibit the penile-specific phosphodiesterase type 5 (PDE5) and enhance the release of nitric oxide thereby increase the levels of cyclic guanosine monophosphate (GMP) that enhances arterial inflow that produces adequate firmness for sexual activity.
The recent drugs for erectile dysfunction which are approved for use by U.
S.
Food and Drugs Administration and other medical and healthcare products regulatory agencies in most countries are; Sildenafil or commercially known as Viagra; Vardenafil hydrochloride with its trade name Levitra; and Tadalafil commercially known as Tadalafil.
Although the three commercial drugs are commonly mass produced for a common problem- erectile dysfunction- the three commercial drugs have varying potency and effects on patients.
Users have varying observations and comments on the drugs in the market which may draw a line of "competition" or barrier or differences between the effectiveness of Tadalafil vs Viagra; Viagra vs Levitra; and Tadalafil vs Levitra.
According to clinical studies, all three drugs have varying success rates.
Usually, the success rates of the three reduced in some patient groups especially those diabetic patients, and patients who have undergone prostatectomy.
The three drugs are inadvisable to patients who use nitroglycerin or nitrate-containing compounds such as doxazosin, terazosin, or tamsulosin for the treatment of benign prostatic hypertrophy or hypertension and other cardiovascular related-diseases.
Medical diagnosis and doctor's prescription must be obtained for these types of medication.
Although there are preliminary concerns raised on the use of PDE5 inhibitors or these ED drugs to patients with cardiovascular ailments, ongoing clinical studies and even clinical experiences of patients with stable cardiovascular diseases who are not using nitroglycerin or nitrate containing compounds suggest that the three drugs are safe.
However, these drugs must be obtained only with prescription from your doctor for a more appropriate medication.
This way too, one can increase the probability of obtaining the most appropriate treatment for his case.
The causes of erectile dysfunction may vary because it involves the integration of psychological, neurological, endocrinal, vascular and anatomical systems of males.
Once there are abnormalities in one or two or any of these systems, erectile dysfunction may take place.
The prevalence of the erectile dysfunction has been noted that through the number of years and years of researches and studies, it was found out that the prevalence of erectile dysfunction increases with age.
With the prevalent problems, remedies and medical treatments were developed, both surgical and nonsurgical.
Today, most patients prefer the non-surgical treatment though there are a lot of treatment approaches to choose from.
It is clear that oral therapy has revolutionized through scientific discoveries of drugs which inhibit the penile-specific phosphodiesterase type 5 (PDE5) and enhance the release of nitric oxide thereby increase the levels of cyclic guanosine monophosphate (GMP) that enhances arterial inflow that produces adequate firmness for sexual activity.
The recent drugs for erectile dysfunction which are approved for use by U.
S.
Food and Drugs Administration and other medical and healthcare products regulatory agencies in most countries are; Sildenafil or commercially known as Viagra; Vardenafil hydrochloride with its trade name Levitra; and Tadalafil commercially known as Tadalafil.
Although the three commercial drugs are commonly mass produced for a common problem- erectile dysfunction- the three commercial drugs have varying potency and effects on patients.
Users have varying observations and comments on the drugs in the market which may draw a line of "competition" or barrier or differences between the effectiveness of Tadalafil vs Viagra; Viagra vs Levitra; and Tadalafil vs Levitra.
According to clinical studies, all three drugs have varying success rates.
Usually, the success rates of the three reduced in some patient groups especially those diabetic patients, and patients who have undergone prostatectomy.
The three drugs are inadvisable to patients who use nitroglycerin or nitrate-containing compounds such as doxazosin, terazosin, or tamsulosin for the treatment of benign prostatic hypertrophy or hypertension and other cardiovascular related-diseases.
Medical diagnosis and doctor's prescription must be obtained for these types of medication.
Although there are preliminary concerns raised on the use of PDE5 inhibitors or these ED drugs to patients with cardiovascular ailments, ongoing clinical studies and even clinical experiences of patients with stable cardiovascular diseases who are not using nitroglycerin or nitrate containing compounds suggest that the three drugs are safe.
However, these drugs must be obtained only with prescription from your doctor for a more appropriate medication.
This way too, one can increase the probability of obtaining the most appropriate treatment for his case.
